tirzepatide news today recency 3 Market Trends, Share and Forecast, 2026-2033 The Next Frontier of Weight

I have never felt better

The SURMOUNT-1 DXA substudy (Look et al., 2025) showed that tirzepatide reduced lean body mass by 10.9% over 72 weeks, compared to 2.6% with placebo

The medication already creates a significant caloric deficit through appetite suppression

People with a history of allergic rhinitis should be aware of these potential changes and discuss any concerns with their healthcare provider

2025, biolongevitylabs.com/research/dsip-delta-sleep-inducing-peptide/?tw_source=google&tw_adid=&tw_campaign=22124776050&tw_kwdid=&gad_source=1&gad_campaignid=22131035699&gbraid=0AAAAA-VNyo4Uc2QKR49_lCuPUVOX6zg2r&gclid=CjwKCAiA_dDIBhB6EiwAvzc1cGN8P24Fn0433DO34wcbGsIJ_fpmMN_5R3L-PEACRcbgLn_HMTZykhoC4zYQAvD_BwE

3.2.2 Neurodegenerative disorder Gut microbiota dysbiosis cause high permeability of the intestine and BBB through the gut-brain axis by increasing LPS, T helper cells, pro inflammatory cytokines